CEGX
is an England-based biosciences company that develops and provides epigenetics-based diagnostic tools for the detection of cancer disease... Read moreCEGX
is an England-based biosciences company that develops and provides epigenetics-based diagnostic tools for the detection of cancer disease... Read more
Co-Founder
Shankar Balasubramanian
News
Jun 14, 2022
FE Investegate
CEGX: Cambridge Epigenetix : Cambridge Epigenetix Names Peter Fromen as Chief Executive Officer
Nov 08, 2021
Global Legal Chronicle
CEGX: Cambridge Epigenetix's $88 Million Series D Funding Round
Nov 02, 2021
FierceBiotech
CEGX: GV-backed Cambridge Epigenetix lines up $88M to roll out genetic sequencing technology
Jan 08, 2019
FinanzNachrichten
CEGX: Cambridge Epigenetix announces programme for routine screening and detection of colorectal cancer and other common tumours
Nov 05, 2017
BioPortfolio
CEGX: Cambridge Epigenetics strengthens leadership team
Aug 16, 2017
BioPortfolio
CEGX: Cambridge Epigenetix and NuGEN Technologies sign partnership agreement to combine leading technologies in epigenetics research.
Aug 15, 2017
Center Watch
CEGX: Cambridge Epigenetix, NuGEN Technologies partner in epigenetics research
Apr 28, 2017
Genetic Engineering & Biotechnology News
CEGX: Cambridge Epigenetix Licenses DNA methylation IP from Boston Children's Hospital
Mar 07, 2017
BioPortfolio
CEGX: Cambridge Epigenetix Establishes Scientific Advisory Board.
Oct 19, 2016
BioPortfolio
CEGX: Cambridge Epigenetix Introduces TrueMethyl Whole Genome Integrated Workflow for Epigenetic Analysis
CEGX Competitors
1
2
3
4
5
6
7
8
9
10